BAK L to A BH3 Synthetic Peptide GQVGRQAAIIGDDINR, CF

BAK L to A BH3 Synthetic Peptide GQVGRQAAIIGDDINR, CF Summary

Product Specifications

Product Datasheets

Carrier Free

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Background: BAK

Bcl-2-antagonist/killer (BAK), also known as BAK1 and Bcl-2-like Protein 7, is a proaptoptotic member of the Bcl-2 protein family with a predicted molecular weight of approximately 23 kDa. It contains four Bcl-2 homology domains, BH1-BH4, and a C-terminal transmembrane domain. Human BAK shares 77% amino acid sequence identity with the mouse and rat orthologs. BAK primarily localizes to the outer mitochondrial membrane where it is redundantly required, along with Bax, for the release of Cytochrome c during apoptosis. Cytochrome c release may occur through pores formed by homo-oligomerization of BAK within the mitochondrial outer membrane. BAK can be directly activated by BID, BIM, and PUMA, which are also members of the Bcl-2 family. Additionally, p53 can directly activate BAK in response to cell stress. BAK may also be involved in crosstalk between the apoptosis and autophagy pathways.

Related Research Areas

• Bcl-2 Proteins and Regulators